Akira Yokomizo

Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria

Hiroshi Katayama, Yukinori Kurokawa, Kenichi Nakamura et al. · Surgery Today · 2015 · 782 citations · Full text

Medicine, Surgery, General Surgery +14

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.

Akira Yokomizo, Mayumi Ono, Hiroki Nanri et al. · PubMed · 1995 · 240 citations

Medicine, Cancer Biology, Oncology +9

Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance

Kohichiroh Yasui, Saori Mihara, Chen Zhao et al. · Cancer Research · 2004 · 220 citations

Medicine, Genetics, Oncology +17